TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23386268

Group type: EXPERIMENTAL
Intervention: Replacement of dietary saturated fats with omega 6 linoleic acid
Number of subjects: 458

Group type: COMPARATOR
Intervention: Updated meta-analysis of linoleic acid intervention trials
Number of subjects: 458
Study: 21040436

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium for 3 days (Group B)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium for 7 days (Group C)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo for 7 days (Group A)
Number of subjects: 66
Study: 18176329

Group type: EXPERIMENTAL
Intervention: Protease inhibitor (PI)
Number of subjects: 1301

Group type: EXPERIMENTAL
Intervention: Non-nucleoside reverse transcriptase inhibitor (NNRTI)
Number of subjects: 1301

Group type: EXPERIMENTAL
Intervention: PI plus NNRTI-based combinations
Number of subjects: 1301
Study: 16633779

Group type: EXPERIMENTAL
Intervention: Desflurane (D)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Propofol (P)
Number of subjects: 50
Study: 12809957

Group type: EXPERIMENTAL
Intervention: Cyclobenzaprine 5 mg TID
Number of subjects: 1405

Group type: EXPERIMENTAL
Intervention: Cyclobenzaprine 10 mg TID
Number of subjects: 1405

Group type: EXPERIMENTAL
Intervention: Cyclobenzaprine 2.5 mg TID
Number of subjects: 1405

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1405
Study: 10768448

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy with progenitor-cell rescue
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional-dose chemotherapy
Number of subjects: 0
Study: 9275441

Group type: EXPERIMENTAL
Intervention: Feedback pulsatile oxytocin system
Number of subjects: 224

Group type: COMPARATOR
Intervention: Continuous intravenous infusion of oxytocin (control group)
Number of subjects: 224
Study: 1511813

Group type: EXPERIMENTAL
Intervention: Low flow oxygen (2 liters/min) via nasal prongs or nasopharyngeal cannula
Number of subjects: 50

Group type: COMPARATOR
Intervention: No oxygen
Number of subjects: 50
Study: 6378245

Group type: EXPERIMENTAL
Intervention: Diluted and undiluted topical corticosteroid preparations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vasoconstrictor assay
Number of subjects: 0
Study: 30209672

Group type: EXPERIMENTAL
Intervention: Video-based training using educational videos and manikins; teachers trained with a BLS/AED course.
Number of subjects: 5146
Study: 28944356

Group type: EXPERIMENTAL
Intervention: Machined implants
Number of subjects: 40

Group type: COMPARATOR
Intervention: Roughened implants
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 25823480

Group type: EXPERIMENTAL
Intervention: Papacarie®
Number of subjects: 25

Group type: COMPARATOR
Intervention: Conventional drilling method
Number of subjects: 25
Study: 24318688

Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia training (HT, FiO2=16.4-14.5%)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Normoxia training (NT, FiO2=21%)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia training (HT)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Normoxia training (NT)
Number of subjects: 22
Study: 21904901

Group type: EXPERIMENTAL
Intervention: lamotrigine (target dose 400 mg/day)
Number of subjects: 117

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 117
Study: 20846382

Group type: EXPERIMENTAL
Intervention: Lipid accumulation product (LAP)
Number of subjects: 6751

Group type: COMPARATOR
Intervention: Waist-to-hip-ratio (WHpR)
Number of subjects: 6751
Study: 17440020

Group type: EXPERIMENTAL
Intervention: Monofluorophosphate (MFP) 20 mg/d
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 14988822

Group type: EXPERIMENTAL
Intervention: Ketamine (NMDA receptor antagonist)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Saline (vehicle)
Number of subjects: 32
Study: 11589718

Group type: EXPERIMENTAL
Intervention: Loop diuretic (LD; bumetanide)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Thiazide diuretic (TD; bendroflumethiazide)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Loop diuretic plus Thiazide diuretic (LD plus TD)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 9716148

Group type: EXPERIMENTAL
Intervention: dilute Russell's Viper Venom Time (dRVVT)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: dilute Kaolin Clotting Time (dKCT)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: polyacrylamide‐immobilised phosphatidylserine column
Number of subjects: 10

Group type: COMPARATOR
Intervention: phospholipid liposomes
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: routine detection of LA antibodies
Number of subjects: 10
Study: 7983959

Group type: EXPERIMENTAL
Intervention: Active treatment (n = 114)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Placebo (n = 119)
Number of subjects: 233
Study: 2574892

Group type: EXPERIMENTAL
Intervention: Subjective Deficit Syndrome Scale (SDSS) assessment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 970902

Group type: EXPERIMENTAL
Intervention: Furosemide prophylaxis (20-60 mg) in LPG
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Furosemide prophylaxis in SPG
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no furosemide prophylaxis)
Number of subjects: 45
Study: 30070753

Group type: EXPERIMENTAL
Intervention: Exenatide once-weekly
Number of subjects: 0
Study: 28326193

Group type: EXPERIMENTAL
Intervention: BMI 25‐<30 kg/m2
Number of subjects: 25554

Group type: EXPERIMENTAL
Intervention: BMI ≥ 30 kg/m2
Number of subjects: 25554

Group type: EXPERIMENTAL
Intervention: Each unit increase in baseline BMI
Number of subjects: 25554

Group type: EXPERIMENTAL
Intervention: Baseline history of diabetes
Number of subjects: 25554

Group type: EXPERIMENTAL
Intervention: Baseline history of diabetes during ≤ 2 years' follow-up
Number of subjects: 25554

Group type: EXPERIMENTAL
Intervention: Baseline history of diabetes during > 2 years' follow-up
Number of subjects: 25554
Study: 25594519

Group type: EXPERIMENTAL
Intervention: Dual-task net-step exercise (NSE) performed once a week for 8 consecutive weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study: 23458849

Group type: EXPERIMENTAL
Intervention: Interactive online intervention
Number of subjects: 189

Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 189
Study: 21388938

Group type: EXPERIMENTAL
Intervention: Maraviroc 300 mg twice daily
Number of subjects: 721

Group type: COMPARATOR
Intervention: Efavirenz 600 mg once daily
Number of subjects: 721
Study: 19283947

Group type: EXPERIMENTAL
Intervention: DVD‐based, peer delivered intervention
Number of subjects: 343

Group type: COMPARATOR
Intervention: NIDA Standard HIV Intervention
Number of subjects: 343

Group type: COMPARATOR
Intervention: Standard practice condition (HIV educational video)
Number of subjects: 343
Study: 16579711

Group type: EXPERIMENTAL
Intervention: Er:YAG laser
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ultrasonic scaler
Number of subjects: 20
Study: 12620955

Group type: EXPERIMENTAL
Intervention: Salbutamol
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Beclomethasone
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Sodium chromoglycate
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control
Number of subjects: 200
Study: 11090872

Group type: EXPERIMENTAL
Intervention: MND Association Survey and ALSAQ‐40 questionnaire
Number of subjects: 500

Group type: COMPARATOR
Intervention: MND Association Survey
Number of subjects: 500
Study: 9198716

Group type: EXPERIMENTAL
Intervention: Eosinophil cationic protein (ECP) concentration in blood serum
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Positive results of prick test
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Increased total IgE concentration
Number of subjects: 53
Study: 8464952

Group type: EXPERIMENTAL
Intervention: 50 mg DMI
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 100 mg DMI
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 3511767

Group type: EXPERIMENTAL
Intervention: Epidural buprenorphine 0.3 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Epidural morphine 4 mg
Number of subjects: 0
Study: 31385000

Group type: EXPERIMENTAL
Intervention: TKA with tourniquet
Number of subjects: 20

Group type: COMPARATOR
Intervention: TKA without tourniquet
Number of subjects: 20
Study: 29255930

Group type: EXPERIMENTAL
Intervention: Folic acid 400 µg/day
Number of subjects: 180

Group type: COMPARATOR
Intervention: Convention (control group)
Number of subjects: 180
Study: 28770664

Group type: EXPERIMENTAL
Intervention: Hippotherapy plus standard care (12 weeks)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 70
Study: 27060461

Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation (NIV)
Number of subjects: 55
Study: 25292137

Group type: EXPERIMENTAL
Intervention: LMWH for 2 days during the perioperative period
Number of subjects: 93

Group type: COMPARATOR
Intervention: LMWH for 7 days during the perioperative period
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: D-dimer > 0.987 mcg/ml and swelling > 1.5 cm of shin
Number of subjects: 93
Study: 22378727

Group type: EXPERIMENTAL
Intervention: Plant sterol (PS) supplementation (1.6 g daily for 4 weeks)
Number of subjects: 25
Study: 19597773

Group type: EXPERIMENTAL
Intervention: Volar locking compression plating
Number of subjects: 120

Group type: COMPARATOR
Intervention: Dorsal plating
Number of subjects: 120
Study: 17505700

Group type: EXPERIMENTAL
Intervention: Low-dose oral contraceptive (15 microg ethinyl estradiol/60 microg gestodene)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study: 16422247

Group type: EXPERIMENTAL
Intervention: HAART (Highly Active Antiretroviral Therapy)
Number of subjects: 20
Study: 11932759

Group type: EXPERIMENTAL
Intervention: 8-month regimen of anti-tuberculous drugs (NTCP recommended)
Number of subjects: 550

Group type: COMPARATOR
Intervention: 6-month regimen of anti-tuberculous drugs
Number of subjects: 550
Study: 9617982

Group type: EXPERIMENTAL
Intervention: Sibutramine 20 mg
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Sibutramine 30 mg
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine 20 mg
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine 30 mg
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31

Group type: COMPARATOR
Intervention: Dextroamphetamine (both doses)
Number of subjects: 31
Study: 7847110

Group type: EXPERIMENTAL
Intervention: Mailing a postcard listing required immunizations followed by telephone contact
Number of subjects: 464

Group type: COMPARATOR
Intervention: Control group (no contact)
Number of subjects: 464
Study: 2681856

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 185

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study: 1205340

Group type: EXPERIMENTAL
Intervention: Dipyridamole and acetylsalicylic acid
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low doses of heparin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 30293457

Group type: EXPERIMENTAL
Intervention: Dynamic elastomeric fabric orthosis 2 h group
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dynamic elastomeric fabric orthosis 6 h group
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (conventional exercise therapy)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dynamic elastomeric fabric orthosis 2 h and 6 h groups
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dynamic elastomeric fabric orthosis groups
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 30976782

Group type: COMPARATOR
Intervention: Baseline portion size
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Increased portion size (50% larger)
Number of subjects: 46
Study: 28374832

Group type: EXPERIMENTAL
Intervention: Home-based approach (group A)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Hospital-based approach (group B)
Number of subjects: 172
Study: 26067429

Group type: EXPERIMENTAL
Intervention: Wet-ice application
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Cold-water immersion
Number of subjects: 54

Group type: COMPARATOR
Intervention: Untreated control condition
Number of subjects: 54
Study: 23008177

Group type: EXPERIMENTAL
Intervention: PCI with MGuard stent
Number of subjects: 432

Group type: COMPARATOR
Intervention: PCI using bare metal or drug-eluting stents (control arm)
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: MGuard stent
Number of subjects: 432
Study: 21287564

Group type: EXPERIMENTAL
Intervention: Active rTMS (1-Hz, 1800 pulses at 110% of motor threshold)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 0
Study: 19185633

Group type: EXPERIMENTAL
Intervention: Intravenous nesiritide
Number of subjects: 7000

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 7000
Study: 16733496

Group type: COMPARATOR
Intervention: Budesonide 9 mg/day (group A)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) 10 mg/day (group B)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Budesonide
Number of subjects: 30

Group type: COMPARATOR
Intervention: Budesonide (group A)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) (group B)
Number of subjects: 30
Study: 15274762

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11379400

Group type: EXPERIMENTAL
Intervention: Epoetin alpha (10,000 U subcutaneously, thrice weekly)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Historical control group (cisplatin and gemcitabine without epoetin alpha)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Epoetin alpha group
Number of subjects: 90

Group type: COMPARATOR
Intervention: Historical control group
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Epoetin alpha
Number of subjects: 90
Study: 9394640

Group type: EXPERIMENTAL
Intervention: Single-gender teams (all men)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Single-gender teams (all women)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Mixed-gender teams
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Team size (2, 3, 4 persons)
Number of subjects: 40
Study: 7955813

Group type: EXPERIMENTAL
Intervention: 600 mg felbamate twice a day
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1200 mg felbamate twice a day
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Coadministration of felbamate (600 mg and 1200 mg)
Number of subjects: 10
Study: 3653463

Group type: EXPERIMENTAL
Intervention: 0.1% domoprednate
Number of subjects: 39

Group type: COMPARATOR
Intervention: hydrocortisone butyrate
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Patient preference for treatment
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Tolerance of treatments
Number of subjects: 39
Study: 28951236

Group type: EXPERIMENTAL
Intervention: Showing the pork roast with the head present
Number of subjects: 0

Group type: COMPARATOR
Intervention: Showing the pork roast with the head removed
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dissociation mechanism
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Disgust and empathy
Number of subjects: 0
Study: 27733193

Group type: EXPERIMENTAL
Intervention: Community-based intensive lifestyle program aimed at achieving weight loss
Number of subjects: 260

Group type: COMPARATOR
Intervention: Clinic-based enhanced diabetes self-management program
Number of subjects: 260
Study: 25675558

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 60

Group type: COMPARATOR
Intervention: Medication (nimodipine and fluoxetine)
Number of subjects: 60
Study: 23754711

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg/day for 6 weeks
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 20429017

Group type: EXPERIMENTAL
Intervention: 40 μA DC electrical stimulation
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 100 μA DC electrical stimulation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (uninstrumented posterolateral fusion)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: All groups (fusion mass BMD)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Smoking status
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Gender
Number of subjects: 80
Study: 18726596

Group type: EXPERIMENTAL
Intervention: Central histopathology review
Number of subjects: 0
Study: 16011133

Group type: EXPERIMENTAL
Intervention: Bimanual technique
Number of subjects: 50

Group type: COMPARATOR
Intervention: One‐handed technique
Number of subjects: 50
Study: 14742935

Group type: EXPERIMENTAL
Intervention: Localized field external radiotherapy 50 Gy/25#/5 wks followed by Boost 10 Gy/5#/1 wk
Number of subjects: 50

Group type: COMPARATOR
Intervention: Whole brain external radiotherapy 40 Gy/20#/4 wks followed by Boost 20 Gy/10#/2 wks
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Localized field external radiotherapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Whole brain external radiotherapy
Number of subjects: 50
Study: 11037003

Group type: EXPERIMENTAL
Intervention: EGb 761 (ginkgo) 240 mg/day or 160 mg/day
Number of subjects: 214

Group type: COMPARATOR
Intervention: Placebo (0 mg/d)
Number of subjects: 214
Study: 8688261

Group type: EXPERIMENTAL
Intervention: Enalapril 50 micrograms kg‐1
Number of subjects: 22

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 22
Study: 1840038

Group type: EXPERIMENTAL
Intervention: P‐ANP 0.3 micrograms.kg‐1 bwt
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: P‐ANP 1.5 micrograms.kg‐1 bwt
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: P‐ANP 3.0 micrograms.kg‐1 bwt
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: P‐ANP
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 6126068

Group type: EXPERIMENTAL
Intervention: Naloxone 0.4 mg
Number of subjects: 1

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 1
Study: 31445873

Group type: EXPERIMENTAL
Intervention: Childhood ADHD
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: Adult ADHD symptom persistence
Number of subjects: 680

Group type: COMPARATOR
Intervention: ADHD desistance
Number of subjects: 680
Study: 31526415

Group type: EXPERIMENTAL
Intervention: External reward intervention
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Elevated threat perception intervention
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Manipulation of a cognitive cluster related to preparedness intervention
Number of subjects: 381

Group type: COMPARATOR
Intervention: Control group 1
Number of subjects: 381

Group type: COMPARATOR
Intervention: Control group 2
Number of subjects: 381
Study: 28398166

Group type: EXPERIMENTAL
Intervention: Power priming condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study: 25643051

Group type: EXPERIMENTAL
Intervention: 100 Hz TEAS
Number of subjects: 60

Group type: COMPARATOR
Intervention: 2 Hz TEAS
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0 Hz (sham) TEAS
Number of subjects: 60
Study: 24237485

Group type: EXPERIMENTAL
Intervention: Positive affect condition
Number of subjects: 120

Group type: COMPARATOR
Intervention: Neutral affect condition
Number of subjects: 120

Group type: COMPARATOR
Intervention: Negative affect condition
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Cognitive flexibility (measured by a switch task)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Divergent thinking
Number of subjects: 120
Study: 21484517

Group type: EXPERIMENTAL
Intervention: Face expertise training
Number of subjects: 0

Group type: COMPARATOR
Intervention: House training (Control)
Number of subjects: 0
Study: 19501439

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa to increase hemoglobin levels to 13 g/dL
Number of subjects: 4044

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4044
Study: 17181457

Group type: EXPERIMENTAL
Intervention: Psychosocial constructs (self‐efficacy, decisional balance, social support, behavior change strategies)
Number of subjects: 441
Study: 15887532

Group type: EXPERIMENTAL
Intervention: Support vector machines (SVM) for gait classification
Number of subjects: 58

Group type: COMPARATOR
Intervention: Neural network for gait classification
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Gait features extracted from MFC plots
Number of subjects: 58
Study: 15821920

Group type: EXPERIMENTAL
Intervention: Autologous serum eye drops
Number of subjects: 23

Group type: COMPARATOR
Intervention: Hyaluronic acid eye drops
Number of subjects: 23
Study: 10232440

Group type: EXPERIMENTAL
Intervention: Bronchial provocation with lysine-aspirin
Number of subjects: 28
Study: 10172710

Group type: EXPERIMENTAL
Intervention: Budesonide 800 micrograms via Turbuhaler
Number of subjects: 0

Group type: COMPARATOR
Intervention: Beclomethasone dipropionate (BDP) 1500 to 2000 micrograms via pressurized metered-dose inhaler with spacer
Number of subjects: 0
Study: 1914375

Group type: EXPERIMENTAL
Intervention: Grapefruit juice (150 ml)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Cimetidine (200 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 9
Study: 6800251

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate
Number of subjects: 19

Group type: COMPARATOR
Intervention: Lead-in phase
Number of subjects: 19
Study: 29704147

Group type: EXPERIMENTAL
Intervention: Chronic marijuana users
Number of subjects: 662

Group type: EXPERIMENTAL
Intervention: Increasers (those who increased marijuana use)
Number of subjects: 662

Group type: EXPERIMENTAL
Intervention: Decreasers (those who decreased marijuana use)
Number of subjects: 662

Group type: COMPARATOR
Intervention: Abstainers
Number of subjects: 662

Group type: EXPERIMENTAL
Intervention: Employment status and perceived workplace stress
Number of subjects: 662
Study: 28846563

Group type: EXPERIMENTAL
Intervention: Resistance training with protein supplementation
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 36
Study: 27306539

Group type: EXPERIMENTAL
Intervention: Dynamic weight‐bearing Assessment of Pain (DAP)
Number of subjects: 100